FERRARINI, MANLIO
 Distribuzione geografica
Continente #
EU - Europa 13.417
AS - Asia 1.303
NA - Nord America 1.043
SA - Sud America 140
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 25
Totale 16.033
Nazione #
IT - Italia 13.195
US - Stati Uniti d'America 965
SG - Singapore 564
CN - Cina 308
VN - Vietnam 212
FR - Francia 114
BD - Bangladesh 105
BR - Brasile 88
HK - Hong Kong 37
FI - Finlandia 29
CA - Canada 26
DE - Germania 21
AR - Argentina 20
CH - Svizzera 16
JP - Giappone 16
MX - Messico 16
JM - Giamaica 10
CO - Colombia 9
GB - Regno Unito 9
IQ - Iraq 9
CL - Cile 8
ZA - Sudafrica 8
NI - Nicaragua 7
PK - Pakistan 7
CR - Costa Rica 6
ID - Indonesia 6
PH - Filippine 6
UA - Ucraina 6
EG - Egitto 5
IE - Irlanda 5
IN - India 5
EC - Ecuador 4
NL - Olanda 4
VE - Venezuela 4
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
SA - Arabia Saudita 3
SV - El Salvador 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
ES - Italia 2
GT - Guatemala 2
HN - Honduras 2
MA - Marocco 2
OM - Oman 2
PL - Polonia 2
PY - Paraguay 2
RU - Federazione Russa 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
KR - Corea 1
LC - Santa Lucia 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
TW - Taiwan 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
Totale 15.929
Città #
Genova 8.373
Genoa 2.812
Rapallo 1.141
Vado Ligure 748
San Jose 266
Singapore 252
Lauterbourg 107
Ashburn 81
Ho Chi Minh City 64
New York 53
Hanoi 46
Beijing 43
Hong Kong 33
Helsinki 29
Santa Clara 28
Los Angeles 20
Bordighera 17
Frankfurt am Main 17
Council Bluffs 15
Tokyo 15
Chicago 14
Zurich 14
Rome 12
Boardman 10
Buffalo 10
Da Nang 10
Mexico City 10
Milan 10
St Louis 10
Brooklyn 9
Phoenix 8
Turin 8
Biên Hòa 7
Haiphong 7
Phủ Lý 7
Dallas 6
Managua 6
Montreal 6
Naples 6
Bologna 5
Cairo 5
Charlotte 5
Florence 5
Kingston 5
Queens 5
San José 5
Baghdad 4
Bari 4
Bogotá 4
Cincinnati 4
City of London 4
Dublin 4
Guangzhou 4
Houston 4
Johannesburg 4
Nampa 4
Orem 4
Philadelphia 4
São Paulo 4
Tampa 4
Washington 4
Amman 3
Atlanta 3
Aurora 3
Brasília 3
Cagliari 3
Columbus 3
Dayton 3
Des Moines 3
Figino 3
Garland 3
Mesa 3
Miami 3
Nairobi 3
Nha Trang 3
Nuremberg 3
Plano 3
San Diego 3
San Francisco 3
Seattle 3
Shanghai 3
The Bronx 3
Amsterdam 2
Anderson 2
Belford Roxo 2
Bensalem 2
Boston 2
Brandywine 2
Cardiff 2
Cedral 2
Changsha 2
Cochabamba 2
Colorado Springs 2
Curitiba 2
Dalian 2
Decatur 2
Denver 2
Destin 2
Dhaka 2
Durban 2
Totale 14.524
Nome #
B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor. 223
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 219
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. 204
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. 202
More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia. 196
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation 186
Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome. 186
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability. 183
APOPTOSIS OR PLASMA CELL DIFFERENTIATION OF CD38-POSITIVE B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY CROSS-LINKING OF SURFACE IGM OR IGD 182
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) 182
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 178
B lymphocytes in humans express ZAP-70 when activated in vivo. 175
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 173
BAFF serum level predicts time to first treatment in early chronic lymphocytic leukemia. 171
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements 167
B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP-70 determination on bone marrow biopsies 166
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients. 166
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia. 164
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. 162
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. 161
Analysis of the stepwise genetic changes that occurred in an AIDS-related Burkitt\'s lymphoma. 160
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 158
The CD38 ectoenzyme family: advances in basic science and clinical practice 157
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. 155
The human marginal zone B cell 154
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 153
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy 153
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. 152
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia 149
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 149
An Increased Number of Individuals with Clinically Recognized Monoclonal B-Cell Lymphocytosis Characterizes a Recent Database of Chronic Lymphocytic Leukemia Rai Stage 0. 148
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T cell cross-priming, depending on their capacity to activate dendritic cells. 147
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. 147
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells 147
Apoptosis of Burkitt\'s lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. 147
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach 147
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. 146
A phase II trial with Cisplatin-Paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. 146
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer. 145
PNAEμ can significantly reduce Burkitt’s Lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease 145
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. 144
Chromosome aberrations evaluated by comparative genomic hybridization in B cell chronic lymphocytic leukemia: correlation with CD38 expression 142
CD38 and chronic lymphocytic leukemia: a decade later. 142
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. 141
CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma 140
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. 140
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukaemia. 139
Evolving view of the in-vivo kinetics of chronic lymphocytic leukemia B cells. 139
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas 139
SUBEPITHELIAL B CELLS IN THE HUMAN PALATINE TONSIL. II. FUNCTIONAL CHARACTERIZATION 139
Chronic lymphocytic leukaemia 138
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. 137
Immunoglobulin Gene Mutation Patterns and Heterogeneity of Marginal Zone Lymphoma 137
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. 137
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. 137
CD 10 is a marker for cycling cells with propensity to apoptosis in childhood ALL 137
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells 136
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia 135
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 135
Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma 134
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. 133
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. 132
Recent views on B cell chronic lymphocytic leukemia pathophysiology 132
Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients. 132
Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. 132
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 131
Identification of three subgroups of B-CELL chronic lymphocytic leukemia based upon mutations of BCL-6 and Ig V genes 130
Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. 130
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. 129
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia. 128
IMMUNOGLOBULIN V GENE MUTAITON STATUS AND CD38 EXPRESSION AS NOVEL PROGNOSTIC INDICATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 127
Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. 127
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. 127
Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. 126
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. 120
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. 120
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. 120
The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. 119
Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter 118
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways 115
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 115
TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EBV-HARBORING B CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT LYMPHOMA CELLS AND NORMAL CENTROBLASTS 113
Frequent mutation of the 5’ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas 113
The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. 113
CD5(+) B cells with the features of subepithelial B cells found in human tonsils 112
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia 112
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 112
Chronic lymphocytic leukemia 111
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica 111
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc 111
Serum-associated inhibition of neutrophil Fc receptors in cancer patients. 111
A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation 110
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma 109
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in earlychronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL)experience. 108
CD38 EXPRESSION DISTINGUISHES TWO GROUPS OF B CELL-CHRONIC LYMPHOCYTIC LEUKEMIAS WITH DIFFERENT RESPONSE TO ANTI IgM ANTIBODIES AND PROPENSITY TO APOPTOSIS 106
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia 106
Heterogeneous expression and function ofIL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells. 106
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 105
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 104
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. 102
Totale 14.137
Categoria #
all - tutte 49.031
article - articoli 48.221
book - libri 0
conference - conferenze 399
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 411
Totale 98.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.239 46 75 91 141 42 69 80 305 53 132 34 171
2022/20231.375 140 91 11 173 228 271 6 124 249 6 65 11
2023/2024663 24 97 13 62 72 135 36 38 28 19 49 90
2024/20251.898 51 157 51 129 227 196 165 269 60 93 229 271
2025/20263.294 368 79 151 290 408 349 555 158 203 345 209 179
2026/2027366 366 0 0 0 0 0 0 0 0 0 0 0
Totale 16.033